Evidence map›Paper›PMID 33281189›Full record

ArticleOncogenesis2020

The HLTF-PARP1 interaction in the progression and stability of damaged replication forks caused by methyl methanesulfonate.

Jia-Lin Shiu, Cheng-Kuei Wu, Song-Bin Chang, Yan-Jhih Sun, Yen-Ju Chen, Chien-Chen Lai, Wen-Tai Chiu, Wen-Tsan Chang, Kyungjae Myung, Wen-Pin Su and 1 more

Open access · goldAbstract read
In one paragraph

Article in Oncogenesis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Jia-Lin ShiuDepartment of Life Sciences, National Cheng Kung University, No.1 University Road, Tainan City, 701, Taiwan.
Cheng-Kuei WuInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, No.138, Sheng Li Road, Tainan City, 704, Taiwan.
Song-Bin ChangDepartment of Life Sciences, National Cheng Kung University, No.1 University Road, Tainan City, 701, Taiwan.
Yan-Jhih SunDepartment of Life Sciences, National Cheng Kung University, No.1 University Road, Tainan City, 701, Taiwan.
Yen-Ju ChenDepartment of Life Sciences, National Cheng Kung University, No.1 University Road, Tainan City, 701, Taiwan.
Chien-Chen LaiInstitute of Molecular Biology, College of Life Science, National Chung Hsing University, No.145 Xingda Rd. South Dist., Taichung City, Taiwan.
Wen-Tai ChiuDepartment of Biomedical Engineering, National Cheng Kung University, Tainan City, Taiwan.ORCID http://orcid.org/0000-0003-0310-0675
Wen-Tsan ChangDepartment of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan City, Taiwan.
Kyungjae MyungIBS Center for Genomic Integrity, UNIST-gil 50, Ulsan, 689-798, Republic of Korea.
Wen-Pin SuInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, No.138, Sheng Li Road, Tainan City, 704, Taiwan. wpsu@mail.ncku.edu.tw.ORCID http://orcid.org/0000-0003-0863-203X
Hungjiun LiawDepartment of Life Sciences, National Cheng Kung University, No.1 University Road, Tainan City, 701, Taiwan. liawh@mail.ncku.edu.tw.ORCID http://orcid.org/0000-0002-3481-709X
National Cheng Kung University · TWCenter for Genomic Science · ITNational Cheng Kung University Hospital · TWNational Chung Hsing University · TW

Funding

Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 106-2311-B-006-003Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 106-2314-B-006-074-MY3Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 107-2311-B-006-003Ministry of Science and Technology, Taiwan (Ministry of Science and Technology of Taiwan) MOST 108-2321-B-006-018
6 · The paper itself

Abstract

Human HLTF participates in the lesion-bypass mechanism through the fork reversal structure, known as template switching of post-replication repair. However, the mechanism by which HLTF promotes the replication progression and fork stability of damaged forks remains unclear. Here, we identify a novel protein-protein interaction between HLTF and PARP1. The depletion of HLTF and PARP1 increases chromosome breaks, further reduces the length of replication tracks, and concomitantly increases the number of stalled forks after methyl methanesulfonate treatment according to a DNA fiber analysis. The progression of replication also depends on BARD1 in the presence of MMS treatment. By combining 5-ethynyl-2'-deoxyuridine with a proximity ligation assay, we revealed that the HLTF, PARP1, and BRCA1/BARD1/RAD51 proteins were initially recruited to damaged forks. However, prolonged stalling of damaged forks results in fork collapse. HLTF and PCNA dissociate from the collapsed forks, with increased accumulation of PARP1 and BRCA1/BARD1/RAD51 at the collapsed forks. Our results reveal that HLTF together with PARP1 and BARD1 participates in the stabilization of damaged forks, and the PARP1-BARD1 interaction is further involved in the repair of collapse forks.

Identifiers

PMID33281189
PMCPMC7719709
OpenAlexW3111526813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.